Position in REGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$43,024
-$10,288 QoQ
Shares Held
69
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,129
of 1,322 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Graney & King, LLC holds $48,692 across 2 Biotechnology names. REGN ranks #1 (88.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
69 | $43,024 | |
| 2 | INCY |
Incyte Corp
|
50 | $5,668 |
All Filings in REGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,024 | 69 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $53,312 | 69 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $53,259 | 69 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $562 | 1 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,100 | 4 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,536 | 4 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $712 | 1 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||